FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

CDER-OPS-ONDQA Organization Chart

The following header reflects the organizational hierarchy.

DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF PHARMACEUTICAL SCIENCE
OFFICE OF NEW DRUG QUALITY ASSESSMENT

The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.

Main telephone: 301-796-1900
Fax: 301-796-9748
Address:
White Oak Bldg. 21, Rm. 2630

10903 New Hampshire Ave.
Silver Spring, MD 20993

The following is the Food and Drug Administration’s, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Office of New Drug Quality Assessment organization structure depicting all the organizational structures reporting to the Office Director. These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).

Each organizational component will be depicted in the following standard format:

Title of organization.
Position title of the manager.
Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.
Standard Administrative code.

OFFICE OF THE DIRECTOR
DIRECTOR
Moheb M. Nasr, Ph.D.
(DBNSC)

DIVISION OF PRE-MARKETING ASSESSMENT I
DIRECTOR
Blair Fraser, Ph.D.
(DBNSCA)

DIVISION OF PRE-MARKETING ASSESSMENT II
DIRECTOR
Elaine Morefield, Ph.D.
(DBNSCB)

DIVISION OF PRE-MARKETING ASSESSMENT III
DIRECTOR
Richard Lostritto, Ph.D.
(DBNSCC)

DIVISION OF POST-MARKETING EVALUATION
DIRECTOR
Eric P. Duffy, Ph.D.
(DBNSCD)

Prepared by the Office of Management Programs, OM - 10/22/08

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff